Capturing Canadian Real-World Data for AML Chemotherapy Ineligible Patients on Venetoclax
LIVEN (P23-363)
NCT05424562
 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Acute Myeloid Leukemia |
Dr. John Storring
Judit Kokai
438-888-1582
|
Radical External Beam Chemoradiation in Patients With Rectal Cancer: a "Wait-and-see" Approach
14-407 GEN
NCT03001362
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Anus |
Dr. Neil Kopek
Tatiana Carvalho
514-934-1934 poste 43698
|
A Phase 3, Randomized Study of Adjuvant Cretostimogene Grenadenorepvec Versus Observation for the Treatment of Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR-NMIBC) Following Transurethral Resection of Bladder Tumor (TURBT)
PIVOT-006
NCT06111235
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Bladder/urothelial |
Dr. Wassim Kassouf
Karla Jauregui Sanchez
514-934-1934
|
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
NRG-BN003
NCT03180268
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Brain |
Dr. Bassam Abdulkarim
Ginette Ricard
514-934-1934 poste 43186
|
A Phase III Trial of Stereotactic Radiosurgery Compared With Whole Brain Radiotherapy (WBRT) for 5-15 Brain Metastases
CE.7
NCT03550391
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Brain |
Dr. Valérie Panet-Raymond
Evelyn Ortega
514-934-1934 poste 48354
|
A Randomized Phase III Trial of Pre-Operative Compared to Post-Operative Stereotactic Radiosurgery in Patients With Resectable Brain Metastases
NRG-BN012
NCT05438212
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Brain |
Dr. Christina Tsien
Tatiana Carvalho
514-934-1934 poste 43698
|
A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
TROPION-Breast05
NCT06103864
Recruiting
|
SITE GLEN
|
Breast |
Dr. Jamil Asselah
Ryan Liu
514-934-1934 poste 34905
|
A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Previously Untreated, Locally Advanced, Inoperable or Metastatic Triple-Negative Breast Cancer Whose Tumors Do Not Express PD-L1 or in Patients Previously Treated With Anti-PD-(L)1 Agents in the Early Setting Whose Tumors Do Express PD-L1
ASCENT-03
NCT05382299
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Breast |
Dr. Jamil Asselah
Elsly Chen
514-934-1934 poste 35391
|
Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ Defined by a Molecular Expression Assay Combined With Clinico-Pathological Features
ELISA
NCT04797299
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Breast |
Dr. Christine Lambert
Marianna Perna
514-934-1934 poste 43191
|
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
MA.39
NCT03488693
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Breast |
Dr. Tarek Hijal
Joshua Trivlidis
514-934-1934 poste 34909
|
Groupe d'étude en oncologie du Québec